Journal article
Prognostic and predictive value of topoisomerase II alpha in a randomized trial comparing CMF to CEF in premenopausal women with node positive breast cancer (NCIC CTG MA.5)
Abstract
533
Authors
O’Malley FP; Chia S; Tu D; Shepherd LE; Levine MN; Huntsman DG; Bramwell VH; Andrulis IL; Pritchard KI
Journal
Journal of Clinical Oncology, Vol. 24, No. 18_suppl, pp. 533–533
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 20, 2006
DOI
10.1200/jco.2006.24.18_suppl.533
ISSN
0732-183X